GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 711 filers reported holding GLAXOSMITHKLINE PLC in Q3 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $26,972,000 | -19.4% | 732,940 | -17.5% | 0.08% | -29.2% |
| Q3 2020 | $33,459,000 | -16.3% | 888,916 | -9.3% | 0.11% | -23.6% |
| Q2 2020 | $39,988,000 | +6.0% | 980,339 | -1.6% | 0.15% | -11.4% |
| Q1 2020 | $37,731,000 | -27.6% | 995,817 | -10.2% | 0.17% | -10.7% |
| Q4 2019 | $52,135,000 | +16.1% | 1,109,488 | +5.5% | 0.19% | +5.6% |
| Q3 2019 | $44,903,000 | +16.6% | 1,052,096 | +9.3% | 0.18% | +12.7% |
| Q2 2019 | $38,521,000 | +3.3% | 962,551 | +7.8% | 0.16% | -2.5% |
| Q1 2019 | $37,300,000 | +30.3% | 892,556 | +19.1% | 0.16% | +11.8% |
| Q4 2018 | $28,634,000 | -10.3% | 749,376 | -5.7% | 0.14% | +2.1% |
| Q3 2018 | $31,928,000 | -0.1% | 794,811 | +0.2% | 0.14% | -7.8% |
| Q2 2018 | $31,974,000 | +25.0% | 793,210 | +21.1% | 0.15% | +20.5% |
| Q1 2018 | $25,589,000 | +75.5% | 654,964 | +59.4% | 0.13% | +71.6% |
| Q4 2017 | $14,578,000 | -25.8% | 410,994 | -15.1% | 0.07% | -33.3% |
| Q3 2017 | $19,650,000 | -8.4% | 483,981 | -2.7% | 0.11% | -15.3% |
| Q2 2017 | $21,459,000 | +18.8% | 497,658 | +16.1% | 0.13% | +6.5% |
| Q1 2017 | $18,066,000 | +30.6% | 428,513 | +19.3% | 0.12% | +16.0% |
| Q4 2016 | $13,834,000 | -46.3% | 359,224 | -39.9% | 0.11% | -43.3% |
| Q3 2016 | $25,775,000 | +8.1% | 597,603 | +8.6% | 0.19% | +0.5% |
| Q2 2016 | $23,846,000 | +2.5% | 550,210 | -4.1% | 0.19% | -6.5% |
| Q1 2016 | $23,269,000 | +4.7% | 573,825 | +4.2% | 0.20% | -2.5% |
| Q4 2015 | $22,226,000 | +4.2% | 550,834 | -0.7% | 0.20% | -6.0% |
| Q3 2015 | $21,323,000 | +25.8% | 554,571 | +36.3% | 0.22% | +24.0% |
| Q2 2015 | $16,951,000 | -23.1% | 406,983 | -14.8% | 0.18% | -29.1% |
| Q1 2015 | $22,036,000 | +33.4% | 477,491 | +23.6% | 0.25% | +21.1% |
| Q4 2014 | $16,513,000 | +8.4% | 386,363 | +16.6% | 0.20% | -1.0% |
| Q3 2014 | $15,227,000 | -32.6% | 331,247 | -21.6% | 0.21% | -37.2% |
| Q2 2014 | $22,595,000 | +4.4% | 422,489 | +4.3% | 0.33% | +7.9% |
| Q1 2014 | $21,640,000 | +11.6% | 405,023 | +11.6% | 0.30% | +1.0% |
| Q4 2013 | $19,383,000 | +15.2% | 363,053 | +8.3% | 0.30% | -7.4% |
| Q3 2013 | $16,825,000 | +19.2% | 335,369 | +18.7% | 0.32% | -3.0% |
| Q2 2013 | $14,117,000 | – | 282,501 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |